NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Collections Health Policy and Services Research Remove constraint Collections: Health Policy and Services Research

Search Results

401. Assisted living and residential care in the states in 2010

403. Association between electronic medical record implementation of default opioid prescription quantities and prescribing behavior in two emergency departments

404. Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents

405. Association of rideshare-based transportation services and missed primary care appointments: a clinical trial

406. Associations between county-level vaccination rates and COVID-19 outcomes among Medicare beneficiaries

407. Associations between county-level vaccination rates and COVID-19 outcomes among Medicare beneficiaries

408. Automatically enrolling eligible children and families into Medicaid and SCHIP: opportunities, obstacles, and options for federal policymakers

409. The availability and usability of behavioral health organization encounter data in MAX 2009

410. Availability and use of enrollment data from the ACA health insurance marketplace

414. BCG-unresponsive nonmuscle invasive bladder cancer: developing drugs and biologics for treatment

416. Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion

418. A balancing act: state long-term care reform

419. Balancing family bonding with newborn safety

420. Barely hanging on: middle-class and uninsured : a state-by-state analysis

421. Barriers to urinary catheter insertion and management practices

422. Basic safety and essential performance of medical electrical equipment, medical electrical systems, and laboratory medical equipment: standards specific information for the Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program : guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff

424. Be prepared: reducing nursing home transfers near end of life

427. Becoming less usual: understanding the decline in the number of people with a usual source of care

431. The Beers Criteria: screening for potentially inappropriate medications in the elderly

433. Behavioral health IT: toward seamless care for California's kids

434. Behavioral health and COVID-19: higher-risk populations and related federal relief funding : report to congressional committees

437. Behavioral health diagnoses and treatment services for children and youth involved with the child welfare system

438. Behavioral health in rural America: challenges and opportunities

440. Behavioral health integration in Medi-Cal: a blueprint for California

441. Behavioral health integration: treating the whole person

442. Behavioral health parity and Medicaid

443. Behavioral health: Available workforce information and federal actions to help recruit and retain providers : report to congressional requesters

444. Being an immigrant with disabilities: characteristics of a population facing multiple structural challenges

445. Belimumab and voclosporin for lupus nephritis: effectiveness and value : final report

447. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: Effectiveness and value : final report

449. Bending the curve: options for achieving savings and improving value in U.S. health spending

450. Bending the employment, income, and cost curves for people with disabilities

451. Bending the obesity cost curve: reducing obesity rates by five percent could lead to more than $29 billion in health care savings in five years

454. Benefits and Services

458. Benefits and services

459. Benefits of the Caregiver Advise, Record, Enable (CARE) Act: 4 perspectives on enhancing patient and family engagement in hospitals

460. Best practices for communication between IND sponsors and FDA during drug development: guidance for industry and review staff : good review practice

462. Best practices for reducing unplanned acute care for patients with cancer

463. Best practices in SHAP outreach, eligibility, and enrollment activities

465. Best practices in specialty provider recruitment and retention: challenges and solutions

466. Betibeglogene autotemcel for beta thalassemia: effectiveness and value : final evidence report

467. Better access to palliative care can improve the experience for metastatic breast cancer patients

468. Better and faster: how safety-net providers are redesigning care

470. A better way: team care for children with special health care needs

474. Beyond health care: the role of social determinants in promoting health and health equity

476. Beyond the bundle: reducing the risk of central line-associated bloodstream infections

477. Beyond the case count: the wide-ranging disparities of COVID-19 in the United States

478. Beyond the count: preventing retention of foreign objects

479. Billing better in CalAIM: how to improve reimbursement for enhanced care management and community supports

480. Billions in estimated Medicare Advantage payments from chart reviews raise concerns

481. Billions in estimated Medicare Advantage payments from diagnoses reported only on health risk assessments raise concerns

482. Bioanalytical method validation

485. Biocompatibility testing of medical devices: standards specific information for the Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program : guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff

486. Biodefense: federal efforts to develop biological threat awareness : report to Congressional requesters

487. Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report

492. The Bipartisan Safer Communities Act: where things stand on the Medicaid and CHIP provisions

495. Birth defects and developmental disabilities: the search for causes and cures

498. Black Lung Benefits Program: oversight is needed to address trust fund solvency strained by bankruptcies : testimony before the Committee on Education and Labor, Subcommittee on Workforce Protections, House of Representatives

499. Black Lung benefits program: continued inaction on coal operator self-insurance increases financial risk to trust fund : testimony before the Committee on Education and Labor, Subcommittee on Workforce Protections, House of Representatives

500. Black and African American adults’ perspectives on discrimination and unfair judgment in health care